They found that compared to delivering antioxidant enzymes regulated by NRF2, such as SOD and CAT, greater cone survival was seen in retinal degeneration mice treated with AAV-NRF2 under the control of a CMV promoter. The gene discussed is NFE2L2; the disease is retinal degeneration.